Sellebjerg F - Search Results

1

Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655.

Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB. Søndergaard HB, et al. Among authors: sellebjerg f. Eur J Hum Genet. 2011 Oct;19(10):1100-3. doi: 10.1038/ejhg.2011.88. Epub 2011 May 25. Eur J Hum Genet. 2011. PMID: 21610746 Free PMC article.

2

Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system.

Sellebjerg F, Frederiksen JL, Olsson T, Link H, Madsen HO, Ryder LP, Svejgaard A. Sellebjerg F, et al. Scand J Immunol. 1994 Jun;39(6):575-80. doi: 10.1111/j.1365-3083.1994.tb03415.x. Scand J Immunol. 1994. PMID: 7516573

3

Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis.

Sellebjerg FT, Frederiksen JL, Olsson T. Sellebjerg FT, et al. Arch Neurol. 1994 Oct;51(10):1032-6. doi: 10.1001/archneur.1994.00540220078017. Arch Neurol. 1994. PMID: 7524468

4

Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis.

Jensen J, Krakauer M, Sellebjerg F. Jensen J, et al. Among authors: sellebjerg f. Eur J Neurol. 2001 Jul;8(4):321-8. doi: 10.1046/j.1468-1331.2001.00232.x. Eur J Neurol. 2001. PMID: 11422428

5

IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS.

Sorensen PS, Haas J, Sellebjerg F, Olsson T, Ravnborg M; TARIMS Study Group. Sorensen PS, et al. Among authors: sellebjerg f. Neurology. 2004 Dec 14;63(11):2028-33. doi: 10.1212/01.wnl.0000145798.61383.39. Neurology. 2004. PMID: 15596745 Clinical Trial.

6

Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.

Ravnborg M, Blinkenberg M, Sellebjerg F, Ballegaard M, Larsen SH, Sørensen PS. Ravnborg M, et al. Among authors: sellebjerg f. Mult Scler. 2005 Feb;11(1):81-4. doi: 10.1191/1352458505ms1120oa. Mult Scler. 2005. PMID: 15732271

7

CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis.

Sellebjerg F, Ross C, Koch-Henriksen N, Sørensen PS, Frederiksen JL, Bendtzen K, Sørensen TL. Sellebjerg F, et al. Mult Scler. 2005 Dec;11(6):641-5. doi: 10.1191/1352458505ms1217oa. Mult Scler. 2005. PMID: 16320722 Clinical Trial.

8

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.

Sellebjerg F, Barnes D, Filippini G, Midgard R, Montalban X, Rieckmann P, Selmaj K, Visser LH, Sørensen PS; EFNS Task Force on Treatment of Multiple Sclerosis Relapses. Sellebjerg F, et al. Eur J Neurol. 2005 Dec;12(12):939-46. doi: 10.1111/j.1468-1331.2005.01352.x. Eur J Neurol. 2005. PMID: 16324087

9

Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.

Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F. Krakauer M, et al. Among authors: sellebjerg f. Scand J Immunol. 2006 Aug;64(2):155-63. doi: 10.1111/j.1365-3083.2006.01788.x. Scand J Immunol. 2006. PMID: 16867161 Free article.

10

CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.

Krakauer M, Sorensen PS, Sellebjerg F. Krakauer M, et al. Among authors: sellebjerg f. J Neuroimmunol. 2006 Dec;181(1-2):157-64. doi: 10.1016/j.jneuroim.2006.09.006. Epub 2006 Nov 1. J Neuroimmunol. 2006. PMID: 17081623 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters